← Back
$APUS All transactions

Apimeds Pharmaceuticals US, Inc.

▲ BUY
5 / 10

Conviction

$ Value

$57K

Shares

28,500

Price

$2

Filed

May 14

Why this score? (5/10)
  • Open market buy (+3)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Koo Jakap

Title

CIK

0002041972

Roles

Director

Transaction Details

Transaction Date

2025-05-12

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

643,885

Footnotes

The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Apimeds Pharmaceuticals US, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. | These shares were sold in multiple transactions at prices ranging from $1.9774 to $2.2000, inclusive.

Filing Info

Accession No.

0001474506-25-000090

Form Type

4

Issuer CIK

0001894525

Koo Jakap's History

Date Ticker Type Value
2025-11-11 APUS A $0
2025-10-15 APUS A $0
2025-05-16 APUS A $0
2025-05-12 APUS $57K

Other Insiders at APUS (90d)

No other insider activity at this issuer in the last 90 days.